Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Reynes

Showing results (121-130 of 200) with videos related to

Pageof 20
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|July 9, 2021
Brief Report: Frailty in Aging People Living With HIV: A Matched Controlled StudyLionel Lellouche, Laure-Anne Gutierrez, Pascale Leclercq, et al.
Mycoses|July 28, 2016
Molecular epidemiology reveals genetic diversity among 363 isolates of the Cryptococcus neoformans and Cryptococcus gattii species complex in 61 Ivorian HIV-positive patientsFulgence K Kassi, Pascal Drakulovski, Virginie Bellet, et al.
The Journal of Antimicrobial Chemotherapy|November 17, 2015
Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial)Lionel Piroth, Laetitia Moinot, Patrick Yeni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 19, 2014
The two human CXCR4 isoforms display different HIV receptor activities: consequences for the emergence of X4 strainsCharline Duquenne, Christina Psomas, Sandrine Gimenez, et al.
JMM Case Reports|March 29, 2017
First case of mixed infection with <i>Cryptococcus deuterogattii</i> and <i>Cryptococcus neoformans</i> VNI in an Ivorian HIV-positive patientFulgence K Kassi, Virginie Bellet, Adama Doumbia, et al.
Antiviral Therapy|October 6, 2016
Evolution of renal function in African patients initiating second-line antiretroviral treatment: findings from the ANRS 12169 2LADY trialAmandine Cournil, Arsène Hema, Sabrina Eymard-Duvernay, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 1, 2018
Hepatitis C virus incidence in HIV-infected and in preexposure prophylaxis (PrEP)-using men having sex with menLaurent Cotte, Eric Cua, Jacques Reynes, et al.
Plos Neglected Tropical Diseases|November 19, 2019
Cryptococcus genetic diversity and mixed infections in Ivorian HIV patients: A follow up studyFulgence Kondo Kassi, Pascal Drakulovski, Virginie Bellet, et al.
The Journal of Antimicrobial Chemotherapy|October 15, 2021
Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life settingColin Deschanvres, Jacques Reynes, Isabelle Lamaury, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2008
Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitroIsabelle Malet, Olivier Delelis, Marc-Antoine Valantin, et al.
Pageof 20

Showing results (121-130 of 200) with videos related to

Sort By:
Pageof 20
Journal of Acquired Immune Deficiency Syndromes (1999)|July 9, 2021
Brief Report: Frailty in Aging People Living With HIV: A Matched Controlled StudyLionel Lellouche, Laure-Anne Gutierrez, Pascale Leclercq, et al.
Mycoses|July 28, 2016
Molecular epidemiology reveals genetic diversity among 363 isolates of the Cryptococcus neoformans and Cryptococcus gattii species complex in 61 Ivorian HIV-positive patientsFulgence K Kassi, Pascal Drakulovski, Virginie Bellet, et al.
The Journal of Antimicrobial Chemotherapy|November 17, 2015
Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial)Lionel Piroth, Laetitia Moinot, Patrick Yeni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 19, 2014
The two human CXCR4 isoforms display different HIV receptor activities: consequences for the emergence of X4 strainsCharline Duquenne, Christina Psomas, Sandrine Gimenez, et al.
JMM Case Reports|March 29, 2017
First case of mixed infection with <i>Cryptococcus deuterogattii</i> and <i>Cryptococcus neoformans</i> VNI in an Ivorian HIV-positive patientFulgence K Kassi, Virginie Bellet, Adama Doumbia, et al.
Antiviral Therapy|October 6, 2016
Evolution of renal function in African patients initiating second-line antiretroviral treatment: findings from the ANRS 12169 2LADY trialAmandine Cournil, Arsène Hema, Sabrina Eymard-Duvernay, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 1, 2018
Hepatitis C virus incidence in HIV-infected and in preexposure prophylaxis (PrEP)-using men having sex with menLaurent Cotte, Eric Cua, Jacques Reynes, et al.
Plos Neglected Tropical Diseases|November 19, 2019
Cryptococcus genetic diversity and mixed infections in Ivorian HIV patients: A follow up studyFulgence Kondo Kassi, Pascal Drakulovski, Virginie Bellet, et al.
The Journal of Antimicrobial Chemotherapy|October 15, 2021
Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life settingColin Deschanvres, Jacques Reynes, Isabelle Lamaury, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2008
Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitroIsabelle Malet, Olivier Delelis, Marc-Antoine Valantin, et al.
Pageof 20